BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins.
2025-11-01
FDA Recalls 500K Bottles of Blood Pressure Drug Over Cancer Risk
A nationwide recall affects more than 500,000 bottles of a common blood pressure drug after ...
